Conference Funding

Overview

Alzheimer's Drug Discovery Foundation

The mission of the Alzheimer's Drug Discovery Foundation is to rapidly accelerate the development of drugs to prevent, treat and cure Alzheimer's disease. Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation (ADDF) is the only charity solely focused on finding drugs for Alzheimer's.

The ADDF focuses on translating the knowledge we have gained about the causes of Alzheimer's disease – known as the “biology of aging” – into drugs to conquer it. We support diverse projects focused on novel targets that hold great promise, but also risk. And most are not far enough along in the drug development pipeline to attract financial support from the pharmaceutical industry, federal funders, or other major partners. By assuming the risk and bridging this critical gap in funding, the ADDF enables leading scientists to pursue pioneering ideas to cure Alzheimer's disease that would otherwise go unexplored.

Conference Funding

The ADDF supports scientific conferences that are relevant to our mission with grants up to $10,000.

Eligibility

_You can learn more about this opportunity by visiting the funder's website._